Therapeutic intervention for Group C: standard-of-care Therapeutic intervention for Group R: standard-of-care and RE therapy
After eight weeks of therapy, fasting plasma insulin and 2-hour postprandial plasma insulin levels in Group R were statistically significantly lower than in Group C.
On the other hand, after eight weeks of therapy, fasting plasma glucose and 2-hour postprandial plasma glucose levels in Group R were statistically significantly lower than in Group C.
From these, adding RE therapy to standard-of-care was inferred to be effective in lowering blood insulin and blood glucose levels simultaneously in patients with metabolic syndrome. The simultaneous decrease in blood insulin and glucose levels implies a reduction in insulin resistance.
